Home/Filings/4/0001209191-18-008548
4//SEC Filing

Graney Thomas 4

Accession 0001209191-18-008548

CIK 0000875320other

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 6:23 PM ET

Size

7.0 KB

Accession

0001209191-18-008548

Insider Transaction Report

Form 4
Period: 2018-02-06
Graney Thomas
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2018-02-06+4,50013,289 total
  • Award

    Stock Option (Right to Buy)

    2018-02-06+10,43610,436 total
    Exercise: $155.57Exp: 2028-02-05Common Stock (10,436 underlying)
Footnotes (2)
  • [F1]Restricted stock unit award that vests in three equal installments on 2/17/2019, 2/17/2020 and 2/17/2021.
  • [F2]The option vests in 16 quarterly installments from 2/6/2018.

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1
  • filerCIK 0001618275

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 6:23 PM ET
Size
7.0 KB